Should we purposefully engineer avian flu strains to become highly transmissible in humans? In our view, no. We believe the benefits of this work do not outweigh the risks. (A column by Thomas V. Inglesby, the chief executive officer and director of the Center for Biosecurity of UPMC in Baltimore and Anita Cicero, chief operating officer and deputy directo and D.A. Henderson, a distinguished scholar.)
Office of Strategic Communication